Global Biologics and Biosimilars Market by Manufacturers, Regions, Type and Application, Forecast 2017 to 2022
Published Date : 2016-12-07
Published By : LP Information
Category : Pharma & Healthcare
No. of Pages : 126
The report Global Biologics and Biosimilars Market by Manufacturers, Regions, Type and Application, Forecast 2017 to 2022 highlights the many market segments of this industry. The report provides extensive researches on market drivers, restrains, opportunities, request factors, market size, conjectures, and patterns influencing the global market over the given time period. Besides, Global Biologics and Biosimilars Market by Manufacturers, Regions, Type and Application, Forecast 2017 to 2022 also gives overview of the technological benefits and bane affecting the market and also includes in-depth analysis of major market players working in the market.
This report studies Biologics and Biosimilars in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top Biologics and Biosimilars Players in each region, with sales, price, revenue and market share for top manufacturer, covering
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top 5 players in these regions, from 2012 to 2017 (forecast), like
North America (United States, Canada and Mexico)
Asia-Pacific (China, Japan, Southeast Asia, India and Korea)
Europe (Germany, UK, France, Italy and Russia etc.
South America (Brazil, Chile, Peru and Argentina)
Middle East and Africa (Egypt, South Africa, Saudi Arabia)
Split by Product Types, with sales, revenue, price, market share of each type, can be divided into
Antibody
Hormone
Growth Factors
Other
Split by applications, this report focuses on sales, market share and growth rate of Biologics and Biosimilars in each application, can be divided into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
The worldwide pharmaceuticals and healthcare industry is encountering steady development because of the overall increment in future, and additionally the expanding rate of incessant and irresistible infections. The relentlessly expanding interest for innovative medications has hence set off a huge ascent in Research and development interests in the pharmaceuticals business. Major industry players dispense around 20% of their turnover to Research and development to keep up an aggressive edge. The rise of biopharmaceuticals has opened another field for drug discovery; and achievements in the fields of proteomics and genomics have likewise empowered medication producers to grow more viable medications and treatments. While the business has started drawing in noteworthy open financing and duty exception, despite everything it faces the difficulties of short item lifecycles and of creating unique drugs. The pharmaceuticals business is commanded by the U.S., which holds around 45% of the worldwide share of the overall industry. However, the business sectors in rising economies like in China and India are required to demonstrate a twofold digit development. This is on account of worldwide pharmaceutical players are progressively outsourcing Research and development to bring down expenses and to exploit the logical work pool in these countries. The pharmaceutical and healthcare associations are working in a dynamic set-up, wherein they are required to join extraordinary advances in demonstrative and remedial methodology, once in a while. It has in this way turn into a tough undertaking for associations to receive rewards from the most recent and upcoming data advancements and offer recognizing oversaw care to patients.
Table of Contents
2017 Top 5 Biologics and Biosimilars Manufacturers/Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
1 Biologics and Biosimilars Market Overview
1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Biologics and Biosimilars Segment by Types
1.2.1 Global Sales Market Share of Biologics and Biosimilars by Types in 2015
1.2.2 Antibody
1.2.3 Hormone
1.2.4 Growth Factors
1.2.5 Other
1.3 Biologics and Biosimilars Segment by Applications
1.3.1 Biologics and Biosimilars Consumption Market Share by Applications in 2015
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Biologics and Biosimilars Market by Regions
1.4.1 North America Status and Prospect (2012-2022)
1.4.2 Asia-Pacific Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 South America Status and Prospect (2012-2022)
1.4.5 Middle East and Africa Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Biologics and Biosimilars (2012-2022)
2 Global Biologics and Biosimilars Sales, Revenue (value) and Market Share by Players
2.1 Global Biologics and Biosimilars Sales and Market Share in 2015 and 2016 by Players
2.2 Global Biologics and Biosimilars Revenue and Market Share by Players in 2015 and 2016
2.3 Global Biologics and Biosimilars Average Price by Players in 2015 and 2016
2.4 Global Biologics and Biosimilars Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Biologics and Biosimilars Market Competitive Situation and Trends
2.5.1 Biologics and Biosimilars Market Concentration Rate
2.5.2 Biologics and Biosimilars Market Share of Top 3 and Top 5 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Global Biologics and Biosimilars Sales, Revenue (Value) by Regions, Type and Application (2012-2017)
3.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Regions (2012-2017)
3.1.1 Global Biologics and Biosimilars Sales and Market Share by Regions (2012-2017)
3.1.2 Global Biologics and Biosimilars Revenue and Market Share by Regions (2012-2017)
3.2 Global Biologics and Biosimilars Sales, Revenue, Market Share and Price by Type (2012-2017)
3.2.1 Global Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
3.2.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
3.2.3 Global Biologics and Biosimilars Price by Type (2012-2017)
3.3 Global Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
3.4 Global Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
4 North America Top 5 Players Biologics and Biosimilars Sales, Revenue and Price
4.1 North America Top 5 Players Biologics and Biosimilars Sales, Revenue and Market Share in 2015 and 2016
4.1.1 North America Top 5 Players Biologics and Biosimilars Sales and Market Share in 2015 and 2016
4.1.2 North America Top 5 Players Biologics and Biosimilars Revenue and Market Share in 2015 and 2016
4.2 North America Biologics and Biosimilars Sales, Revenue, Market Share and Price by Type (2012-2017)
4.2.1 North America Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
4.2.2 North America Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
4.2.3 North America Biologics and Biosimilars Price by Type (2012-2017)
4.3 North America Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
4.4 North America Biologics and Biosimilars Sales and Market Share by Country (US, Canada and Mexico) (2012-2017)
4.5 North America Biologics and Biosimilars Import & Export (2012-2017)
5 Europe Top 5 Players Biologics and Biosimilars Sales, Revenue and Price
5.1 Europe Top 5 Players Biologics and Biosimilars Sales, Revenue and Market Share in 2015 and 2016
5.1.1 Europe Top 5 Players Biologics and Biosimilars Sales and Market Share in 2015 and 2016
5.1.2 Europe Top 5 Players Biologics and Biosimilars Revenue and Market Share in 2015 and 2016
5.2 Europe Biologics and Biosimilars Sales, Revenue, Market Share and Price by Type (2012-2017)
5.2.1 Europe Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
5.2.2 Europe Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
5.2.3 Europe Biologics and Biosimilars Price by Type (2012-2017)
5.3 Europe Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
5.4 Europe Biologics and Biosimilars Sales and Market Share by Country (Germany, UK, France, Italy and Russia) (2012-2017)
5.5 Europe Biologics and Biosimilars Import & Export (2012-2017)
6 Asia-Pacific Top 5 Players Biologics and Biosimilars Sales, Revenue and Price
6.1 Asia-Pacific Top 5 Players Biologics and Biosimilars Sales, Revenue and Market Share in 2015 and 2016
6.1.1 Asia-Pacific Top 5 Players Biologics and Biosimilars Sales and Market Share in 2015 and 2016
6.1.2 Asia-Pacific Top 5 Players Biologics and Biosimilars Revenue and Market Share in 2015 and 2016
6.2 Asia-Pacific Biologics and Biosimilars Sales, Revenue, Market Share and Price by Type (2012-2017)
6.2.1 Asia-Pacific Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
6.2.2 Asia-Pacific Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
6.2.3 Asia-Pacific Biologics and Biosimilars Price by Type (2012-2017)
6.3 Asia-Pacific Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
6.4 Asia-Pacific Biologics and Biosimilars Sales and Market Share by Country (China, Japan, Southeast Asia, India and Korea) (2012-2017)
6.5 Asia-Pacific Biologics and Biosimilars Import & Export (2012-2017)
7 South America Top 5 Players Biologics and Biosimilars Sales, Revenue and Price
7.1 South America Top 5 Players Biologics and Biosimilars Sales, Revenue and Market Share in 2015 and 2016
7.1.1 South America Top 5 Players Biologics and Biosimilars Sales and Market Share in 2015 and 2016
7.1.2 South America Top 5 Players Biologics and Biosimilars Revenue and Market Share in 2015 and 2016
7.2 South America Biologics and Biosimilars Sales, Revenue, Market Share and Price by Type (2012-2017)
7.2.1 South America Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
7.2.2 South America Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
7.2.3 South America Biologics and Biosimilars Price by Type (2012-2017)
7.3 South America Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
7.4 South America Biologics and Biosimilars Sales and Market Share by Country (Brazil, Argentina, Chile and Peru) (2012-2017)
7.5 South America Biologics and Biosimilars Import & Export (2012-2017)
8 Middle East & Africa Top 5 Players Biologics and Biosimilars Sales, Revenue and Price
8.1 Middle East & Africa Top 5 Players Biologics and Biosimilars Sales, Revenue and Market Share in 2015 and 2016
8.1.1 Middle East & Africa Top 5 Players Biologics and Biosimilars Sales and Market Share in 2015 and 2016
8.1.2 Middle East & Africa Top 5 Players Biologics and Biosimilars Revenue and Market Share in 2015 and 2016
8.2 Middle East & Africa Biologics and Biosimilars Sales, Revenue, Market Share and Price by Type (2012-2017)
8.2.1 Middle East & Africa Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
8.2.2 Middle East & Africa Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
8.2.3 Middle East & Africa Biologics and Biosimilars Price by Type (2012-2017)
8.3 Middle East & Africa Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
8.4 Middle East & Africa Biologics and Biosimilars Sales and Market Share by Country (Egypt, Saudi Arabia, South Africa and Iran) (2012-2017)
8.5 Middle East & Africa Biologics and Biosimilars Import & Export (2012-2017)
9 Global Biologics and Biosimilars Players Profiles/Analysis
9.1 Roche
9.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.1.2 Biologics and Biosimilars Product Types, Application and Specification
9.1.2.1 Type 1
9.1.2.2 Type 2
9.1.3 Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Amgen
9.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.2.2 Biologics and Biosimilars Product Types, Application and Specification
9.2.2.1 Type 1
9.2.2.2 Type 2
9.2.3 Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 AbbVie
9.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.3.2 Biologics and Biosimilars Product Types, Application and Specification
9.3.2.1 Type 1
9.3.2.2 Type 2
9.3.3 AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Sanofi-Aventis
9.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.4.2 Biologics and Biosimilars Product Types, Application and Specification
9.4.2.1 Type 1
9.4.2.2 Type 2
9.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Johnson & Johnson
9.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.5.2 Biologics and Biosimilars Product Types, Application and Specification
9.5.2.1 Type 1
9.5.2.2 Type 2
9.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Pfizer
9.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.6.2 Biologics and Biosimilars Product Types, Application and Specification
9.6.2.1 Type 1
9.6.2.2 Type 2
9.6.3 Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Novo Nordisk
9.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.7.2 Biologics and Biosimilars Product Types, Application and Specification
9.7.2.1 Type 1
9.7.2.2 Type 2
9.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Eli Lilly
9.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.8.2 Biologics and Biosimilars Product Types, Application and Specification
9.8.2.1 Type 1
9.8.2.2 Type 2
9.8.3 Eli Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Novartis
9.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.9.2 Biologics and Biosimilars Product Types, Application and Specification
9.9.2.1 Type 1
9.9.2.2 Type 2
9.9.3 Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Merck
9.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.10.2 Biologics and Biosimilars Product Types, Application and Specification
9.10.2.1 Type 1
9.10.2.2 Type 2
9.10.3 Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 3sbio
9.11.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.11.2 Biologics and Biosimilars Product Types, Application and Specification
9.11.2.1 Type 1
9.11.2.2 Type 2
9.11.3 3sbio Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.11.4 Main Business/Business Overview
9.12 Changchun High Tech
9.12.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.12.2 Biologics and Biosimilars Product Types, Application and Specification
9.12.2.1 Type 1
9.12.2.2 Type 2
9.12.3 Changchun High Tech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.12.4 Main Business/Business Overview
9.13 CP Guojian
9.13.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.13.2 Biologics and Biosimilars Product Types, Application and Specification
9.13.2.1 Type 1
9.13.2.2 Type 2
9.13.3 CP Guojian Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.13.4 Main Business/Business Overview
9.14 Biotech
9.14.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.14.2 Biologics and Biosimilars Product Types, Application and Specification
9.14.2.1 Type 1
9.14.2.2 Type 2
9.14.3 Biotech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.14.4 Main Business/Business Overview
9.15 Gelgen
9.15.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.15.2 Biologics and Biosimilars Product Types, Application and Specification
9.15.2.1 Type 1
9.15.2.2 Type 2
9.15.3 Gelgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.15.4 Main Business/Business Overview
9.16 Innovent
9.16.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.16.2 Biologics and Biosimilars Product Types, Application and Specification
9.16.2.1 Type 1
9.16.2.2 Type 2
9.16.3 Innovent Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.16.4 Main Business/Business Overview
9.17 Dong Bao
9.17.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.17.2 Biologics and Biosimilars Product Types, Application and Specification
9.17.2.1 Type 1
9.17.2.2 Type 2
9.17.3 Dong Bao Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.17.4 Main Business/Business Overview
9.18 Ganlee
9.18.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.18.2 Biologics and Biosimilars Product Types, Application and Specification
9.18.2.1 Type 1
9.18.2.2 Type 2
9.18.3 Ganlee Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.18.4 Main Business/Business Overview
9.19 United Laboratories
9.19.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.19.2 Biologics and Biosimilars Product Types, Application and Specification
9.19.2.1 Type 1
9.19.2.2 Type 2
9.19.3 United Laboratories Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.19.4 Main Business/Business Overview
10 Biologics and Biosimilars Manufacturing Cost Analysis
10.1 Biologics and Biosimilars Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Expenses
10.3 Manufacturing Process Analysis of Biologics and Biosimilars
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Biologics and Biosimilars Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Biologics and Biosimilars Major Players in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Biologics and Biosimilars Market Forecast (2017-2022)
14.1 Global Biologics and Biosimilars Sales, Revenue Forecast (2017-2022)
14.2 Global Biologics and Biosimilars Sales, Consumption Forecast by Regions (2017-2022)
14.3 Global Biologics and Biosimilars Sales Forecast by Type (2017-2022)
14.4 Global Biologics and Biosimilars Sales Forecast by Application (2017-2022)
14.5 Biologics and Biosimilars Price Forecast (2017-2022)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Analyst Introduction
16.3 Data Source
List of Tables and Figures
Figure Picture of Biologics and Biosimilars
Table Product Specifications of Biologics and Biosimilars
Figure Global Sales Market Share of Biologics and Biosimilars by Types in 2015
Table Types of Biologics and Biosimilars
Figure Product Picture of Antibody
Table Major Players of Antibody
Figure Product Picture of Hormone
Table Major Players of Hormone
Figure Product Picture of Growth Factors
Table Major Players of Growth Factors
Figure Product Picture of Other
Table Major Players of Other
Table Biologics and Biosimilars Consumption Market Share by Applications in 2015
Table Applications of Biologics and Biosimilars
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure Hemophilia Examples
Figure Other Examples
Figure North America Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure South America Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East and Africa Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Table Global Biologics and Biosimilars Sales by Players in 2015 and 2016
Table Global Biologics and Biosimilars Sales Market Share (%) by Players in 2015 and 2016
Figure Global Biologics and Biosimilars Sales Share by Players in 2015
Figure Global Biologics and Biosimilars Sales Share by Players in 2016
Table Global Biologics and Biosimilars Revenue by Players in 2015 and 2016
Table Global Biologics and Biosimilars Revenue Market Share (%) by Players in 2015 and 2016
Figure Global Biologics and Biosimilars Revenue Share by Players in 2015
Figure Global Biologics and Biosimilars Revenue Share by Players in 2016
Table Global Biologics and Biosimilars Average Price by Players in 2015 and 2016
Table Global Biologics and Biosimilars Average Price by Players in 2016
Table Global Biologics and Biosimilars Manufacturing Base Distribution and Sales Area by Players
Table Players Biologics and Biosimilars Product Types
Figure Biologics and Biosimilars Market Share of Top 3 Players
Figure Biologics and Biosimilars Market Share of Top 5 Players
Table Global Biologics and Biosimilars Sales by Regions (2012-2017)
Table Global Biologics and Biosimilars Sales and Market Share by Regions (2012-2017)
Figure Global Biologics and Biosimilars Sales Market Share by Regions (2012-2017)
Figure 2016 Global Biologics and Biosimilars Sales Market Share by Regions
Table Global Biologics and Biosimilars Revenue by Regions (2012-2017)
Table Global Biologics and Biosimilars Revenue and Market Share by Regions (2012-2017)
Figure Global Biologics and Biosimilars Revenue Market Share by Regions (2012-2017)
Figure 2016 Global Biologics and Biosimilars Revenue Market Share by Regions
Table Global Biologics and Biosimilars Sales by Type (2012-2017)
Table Global Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Global Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Global Biologics and Biosimilars Sales Market Share by Type
Table Global Biologics and Biosimilars Revenue by Type (2012-2017)
Table Global Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Global Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Global Biologics and Biosimilars Revenue Market Share by Type
Table Global Biologics and Biosimilars Price by Type (2012-2017)
Table Global Biologics and Biosimilars Sales by Application (2012-2017)
Table Global Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Global Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Global Biologics and Biosimilars Sales Market Share by Application
Table Global Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table North America Top 5 Players Biologics and Biosimilars Sales in 2015 and 2016
Table North America Top 5 Players Biologics and Biosimilars Sales Market Share (%) in 2015 and 2016
Figure North America Top 5 Players Biologics and Biosimilars Sales Share in 2015
Figure North America Top 5 Players Biologics and Biosimilars Sales Share in 2016
Table North America Top 5 Players Biologics and Biosimilars Revenue in 2015 and 2016
Table North America Top 5 Players Biologics and Biosimilars Revenue Market Share (%) in 2015 and 2016
Figure North America Top 5 Players Biologics and Biosimilars Revenue Share in 2015
Figure North America Top 5 Players Biologics and Biosimilars Revenue Share in 2016
Table North America Biologics and Biosimilars Sales by Type (2012-2017)
Table North America Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure North America Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 North America Biologics and Biosimilars Sales Market Share by Type
Table North America Biologics and Biosimilars Revenue by Type (2012-2017)
Table North America Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure North America Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 North America Biologics and Biosimilars Revenue Market Share by Type
Table North America Biologics and Biosimilars Price by Type (2012-2017)
Table North America Biologics and Biosimilars Sales by Application (2012-2017)
Table North America Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure North America Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 North America Biologics and Biosimilars Sales Market Share by Application
Table North America Biologics and Biosimilars Sales by Country (2012-2017)
Table North America Biologics and Biosimilars Sales Market Share by Country (2012-2017)
Figure North America Biologics and Biosimilars Sales Market Share by Country (2012-2017)
Figure 2016 North America Biologics and Biosimilars Sales Market Share by Country
Table North America Biologics and Biosimilars Import & Export (2012-2017)
Table Europe Top 5 Players Biologics and Biosimilars Sales in 2015 and 2016
Table Europe Top 5 Players Biologics and Biosimilars Sales Market Share (%) in 2015 and 2016
Figure Europe Top 5 Players Biologics and Biosimilars Sales Share in 2015
Figure Europe Top 5 Players Biologics and Biosimilars Sales Share in 2016
Table Europe Top 5 Players Biologics and Biosimilars Revenue in 2015 and 2016
Table Europe Top 5 Players Biologics and Biosimilars Revenue Market Share (%) in 2015 and 2016
Figure Europe Top 5 Players Biologics and Biosimilars Revenue Share in 2015
Figure Europe Top 5 Players Biologics and Biosimilars Revenue Share in 2016
Table Europe Biologics and Biosimilars Sales by Type (2012-2017)
Table Europe Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Europe Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Europe Biologics and Biosimilars Sales Market Share by Type
Table Europe Biologics and Biosimilars Revenue by Type (2012-2017)
Table Europe Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Europe Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Europe Biologics and Biosimilars Revenue Market Share by Type
Table Europe Biologics and Biosimilars Price by Type (2012-2017)
Table Europe Biologics and Biosimilars Sales by Application (2012-2017)
Table Europe Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Europe Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Europe Biologics and Biosimilars Sales Market Share by Application
Table Europe Biologics and Biosimilars Sales by Country (2012-2017)
Table Europe Biologics and Biosimilars Sales Market Share by Country (2012-2017)
Figure Europe Biologics and Biosimilars Sales Market Share by Country (2012-2017)
Figure 2016 Europe Biologics and Biosimilars Sales Market Share by Country
Table Europe Biologics and Biosimilars Import & Export (2012-2017)
Table Asia-Pacific Top 5 Players Biologics and Biosimilars Sales in 2015 and 2016
Table Asia-Pacific Top 5 Players Biologics and Biosimilars Sales Market Share (%) in 2015 and 2016
Figure Asia-Pacific Top 5 Players Biologics and Biosimilars Sales Share in 2015
Figure Asia-Pacific Top 5 Players Biologics and Biosimilars Sales Share in 2016
Table Asia-Pacific Top 5 Players Biologics and Biosimilars Revenue in 2015 and 2016
Table Asia-Pacific Top 5 Players Biologics and Biosimilars Revenue Market Share (%) in 2015 and 2016
Figure Asia-Pacific Top 5 Players Biologics and Biosimilars Revenue Share in 2015
Figure Asia-Pacific Top 5 Players Biologics and Biosimilars Revenue Share in 2016
Table Asia-Pacific Biologics and Biosimilars Sales by Type (2012-2017)
Table Asia-Pacific Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Asia-Pacific Biologics and Biosimilars Sales Market Share by Type
Table Asia-Pacific Biologics and Biosimilars Revenue by Type (2012-2017)
Table Asia-Pacific Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Asia-Pacific Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Asia-Pacific Biologics and Biosimilars Revenue Market Share by Type
Table Asia-Pacific Biologics and Biosimilars Price by Type (2012-2017)
Table Asia-Pacific Biologics and Biosimilars Sales by Application (2012-2017)
Table Asia-Pacific Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Asia-Pacific Biologics and Biosimilars Sales Market Share by Application
Table Asia-Pacific Biologics and Biosimilars Sales by Country (2012-2017)
Table Asia-Pacific Biologics and Biosimilars Sales Market Share by Country (2012-2017)
Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Country (2012-2017)
Figure 2016 Asia-Pacific Biologics and Biosimilars Sales Market Share by Country
Table Asia-Pacific Biologics and Biosimilars Import & Export (2012-2017)
Table South America Top 5 Players Biologics and Biosimilars Sales in 2015 and 2016
Table South America Top 5 Players Biologics and Biosimilars Sales Market Share (%) in 2015 and 2016
Figure South America Top 5 Players Biologics and Biosimilars Sales Share in 2015
Figure South America Top 5 Players Biologics and Biosimilars Sales Share in 2016
Table South America Top 5 Players Biologics and Biosimilars Revenue in 2015 and 2016
Table South America Top 5 Players Biologics and Biosimilars Revenue Market Share (%) in 2015 and 2016
Figure South America Top 5 Players Biologics and Biosimilars Revenue Share in 2015
Figure South America Top 5 Players Biologics and Biosimilars Revenue Share in 2016
Table South America Biologics and Biosimilars Sales by Type (2012-2017)
Table South America Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure South America Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 South America Biologics and Biosimilars Sales Market Share by Type
Table South America Biologics and Biosimilars Revenue by Type (2012-2017)
Table South America Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure South America Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 South America Biologics and Biosimilars Revenue Market Share by Type
Table South America Biologics and Biosimilars Price by Type (2012-2017)
Table South America Biologics and Biosimilars Sales by Application (2012-2017)
Table South America Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure South America Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 South America Biologics and Biosimilars Sales Market Share by Application
Table South America Biologics and Biosimilars Sales by Country (2012-2017)
Table South America Biologics and Biosimilars Sales Market Share by Country (2012-2017)
Figure South America Biologics and Biosimilars Sales Market Share by Country (2012-2017)
Figure 2016 South America Biologics and Biosimilars Sales Market Share by Country
Table South America Biologics and Biosimilars Import & Export (2012-2017)
Table Middle East & Africa Top 5 Players Biologics and Biosimilars Sales in 2015 and 2016
Table Middle East & Africa Top 5 Players Biologics and Biosimilars Sales Market Share (%) in 2015 and 2016
Figure Middle East & Africa Top 5 Players Biologics and Biosimilars Sales Share in 2015
Figure Middle East & Africa Top 5 Players Biologics and Biosimilars Sales Share in 2016
Table Middle East & Africa Top 5 Players Biologics and Biosimilars Revenue in 2015 and 2016
Table Middle East & Africa Top 5 Players Biologics and Biosimilars Revenue Market Share (%) in 2015 and 2016
Figure Middle East & Africa Top 5 Players Biologics and Biosimilars Revenue Share in 2015
Figure Middle East & Africa Top 5 Players Biologics and Biosimilars Revenue Share in 2016
Table Middle East & Africa Biologics and Biosimilars Sales by Type (2012-2017)
Table Middle East & Africa Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Figure Middle East & Africa Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure 2016 Middle East & Africa Biologics and Biosimilars Sales Market Share by Type
Table Middle East & Africa Biologics and Biosimilars Revenue by Type (2012-2017)
Table Middle East & Africa Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Figure Middle East & Africa Biologics and Biosimilars Revenue Market Share by Type (2012-2017)
Figure 2016 Middle East & Africa Biologics and Biosimilars Revenue Market Share by Type
Table Middle East & Africa Biologics and Biosimilars Price by Type (2012-2017)
Table Middle East & Africa Biologics and Biosimilars Sales by Application (2012-2017)
Table Middle East & Africa Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Figure Middle East & Africa Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure 2016 Middle East & Africa Biologics and Biosimilars Sales Market Share by Application
Table Middle East & Africa Biologics and Biosimilars Sales by Country (2012-2017)
Table Middle East & Africa Biologics and Biosimilars Sales Market Share by Country (2012-2017)
Figure Middle East & Africa Biologics and Biosimilars Sales Market Share by Country (2012-2017)
Figure 2016 Middle East & Africa Biologics and Biosimilars Sales Market Share by Country
Table Middle East & Africa Biologics and Biosimilars Import & Export (2012-2017)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Biologics and Biosimilars Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Biologics and Biosimilars Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AbbVie Biologics and Biosimilars Market Share (2012-2017)
Table Sanofi-Aventis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi-Aventis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi-Aventis Biologics and Biosimilars Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Biologics and Biosimilars Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Biologics and Biosimilars Market Share (2012-2017)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Biologics and Biosimilars Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Biologics and Biosimilars Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Biologics and Biosimilars Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Biologics and Biosimilars Market Share (2012-2017)
Table 3sbio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 3sbio Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure 3sbio Biologics and Biosimilars Market Share (2012-2017)
Table Changchun High Tech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Changchun High Tech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Changchun High Tech Biologics and Biosimilars Market Share (2012-2017)
Table CP Guojian Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CP Guojian Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CP Guojian Biologics and Biosimilars Market Share (2012-2017)
Table Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biotech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biotech Biologics and Biosimilars Market Share (2012-2017)
Table Gelgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gelgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Gelgen Biologics and Biosimilars Market Share (2012-2017)
Table Innovent Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Innovent Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Innovent Biologics and Biosimilars Market Share (2012-2017)
Table Dong Bao Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dong Bao Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Dong Bao Biologics and Biosimilars Market Share (2012-2017)
Table Ganlee Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ganlee Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ganlee Biologics and Biosimilars Market Share (2012-2017)
Table United Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table United Laboratories Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure United Laboratories Biologics and Biosimilars Market Share (2012-2017)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics and Biosimilars
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics and Biosimilars Major Players in 2015
Table Major Buyers of Biologics and Biosimilars
Table Distributors/Traders List
Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast (2017-2022)
Figure Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2017-2022)
Table Global Biologics and Biosimilars Sales Forecast by Regions (2017-2022)
Table Global Biologics and Biosimilars Sales Market Share Forecast by Regions (2017-2022)
Table Global Biologics and Biosimilars Sales Forecast by Type (2017-2022)
Table Global Biologics and Biosimilars Sales Forecast by Application (2017-2022)
Research Assistance
We will be happy to help you find what you need. Please write to us:
+1-888-236-2744